Narci, K. Et Al. 2022. Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.. BMC cancer , vol.22, no.1 , 320.

Narci, K., Kahraman, D. C., Koyas, A., Ersahin, T., Tuncbag, N., & Atalay, R. C., (2022). Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.. BMC cancer , vol.22, no.1, 320.

Narci, Kubra Et Al. "Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.," BMC cancer , vol.22, no.1, 320, 2022

Narci, Kubra Et Al. "Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.." BMC cancer , vol.22, no.1, pp.320, 2022

Narci, K. Et Al. (2022) . "Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.." BMC cancer , vol.22, no.1, p.320.

@article{article, author={Kubra Narci Et Al. }, title={Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.}, journal={BMC cancer}, year=2022, pages={320} }